FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899272865> ?p ?o ?g. }

• W2899272865 abstract "ABSTRACT The efficacy of lidocaine-prilocaine cream (EMLA® — Eutectic mixture of Local Anesthetics) in alleviating the pain of intramuscular injections was investigated in a randomized, double-blind, placebo-controlled, parallel group trial. EMLA® or placebo cream was applied to the arms of 60 adult volunteers before receiving influenza virus vaccine (Fluzone®). Twenty-nine subjects received approximately 2.5 g of EMLA® cream and 31 subjects received approximately 2.5 g of an inert placebo cream under occlusion for 60-90 minutes. The cream was then removed and each subject received one 0.5 mL intramuscular injection of influenza virus vaccine using a 22 gauge one inch needle. Pain of needle puncture and pain of injection were both assessed by the subjects using a visual analog scale. EMLA® was associated with decreased needle puncture pain (p < 0.0002) and decreased pain of injection when compared to placebo (p = 0.0139). There was a significant correlation between scores of needle puncture pain and injection pain. Mild skin pallor was a common skin reaction from EMILA®· While the efficacy of EMLA® to alleviate pain of venipuncture is well documented, this is the first study to show the efficacy of EMLA ® for intramuscular injections. RESUME Une etude randomisee a double insu, en controle parallele avec placebo a permis d'evaluer la capacite de la Lidocaine-Prilocaine (creme EMLA® — melange eutectique d'anesthesiques locaux) a soulager la douleur causee par les injections intramusculaires. On a applique la creme EMLA® ou un placebo sur le bras de 60 volontaires adultes avant de leur injecter un vaccin viral contre la grippe (Fluzone®). Vingt-neuf (29) sujets ont ete traites avec la creme EMLA® et 31 avec le placebo. Tous ont recu une application d'environ 2,5 g de creme sous un pansement occlusif pendant 60 a 90 minutes. Apres l'elimination de la creme, on leur a injecte 0,5 mL de vaccin par voie intramusculaire au moyen d'une aiguille calibre 22 d'un pouce. Les sujets ont evalue la douleur causee par l’insertion de l'aiguille et par l'injection au moyen d'une echelle visuelle analogique. Comparativement au placebo, la creme EMLA® a attenue la douleur associee a l'insertion de l’aiguille (p < 0.0002) et a l’injection (P = 0,0139). On a note une correlation significative entre les cotes se rapportant a la douleur provoquee par l'insertion de l'aiguille et celles relatives a la douleur causee par l'injection. L'apparition d'une legere pâleur fut une reaction cutanee courante a l'application de la creme EMLA®. Il est bien etabli que cette derniere soulage la douleur due a la ponction veineuse, mais la presente etude est la premieree a demontrer son efficacite en cas d'injection intramusculaire." @default.
• W2899272865 created "2018-11-09" @default.
• W2899272865 creator A5026206882 @default.
• W2899272865 creator A5037904271 @default.
• W2899272865 creator A5043282888 @default.
• W2899272865 creator A5071533922 @default.
• W2899272865 creator A5082218200 @default.
• W2899272865 date "2018-07-08" @default.
• W2899272865 modified "2023-09-23" @default.
• W2899272865 title "Effect of Lidocaine-Prilocaine Cream (EMLA®) on Pain of Intramuscular Fluzone® Injection" @default.
• W2899272865 doi "https://doi.org/10.4212/cjhp.v45i6.2673" @default.
• W2899272865 hasPublicationYear "2018" @default.
• W2899272865 type Work @default.
• W2899272865 sameAs 2899272865 @default.
• W2899272865 citedByCount "5" @default.
• W2899272865 countsByYear W28992728652013 @default.
• W2899272865 countsByYear W28992728652019 @default.
• W2899272865 crossrefType "journal-article" @default.
• W2899272865 hasAuthorship W2899272865A5026206882 @default.
• W2899272865 hasAuthorship W2899272865A5037904271 @default.
• W2899272865 hasAuthorship W2899272865A5043282888 @default.
• W2899272865 hasAuthorship W2899272865A5071533922 @default.
• W2899272865 hasAuthorship W2899272865A5082218200 @default.
• W2899272865 hasConcept C141071460 @default.
• W2899272865 hasConcept C142724271 @default.
• W2899272865 hasConcept C204787440 @default.
• W2899272865 hasConcept C27081682 @default.
• W2899272865 hasConcept C2776291583 @default.
• W2899272865 hasConcept C2778994108 @default.
• W2899272865 hasConcept C2780149897 @default.
• W2899272865 hasConcept C2780560023 @default.
• W2899272865 hasConcept C42219234 @default.
• W2899272865 hasConcept C71924100 @default.
• W2899272865 hasConceptScore W2899272865C141071460 @default.
• W2899272865 hasConceptScore W2899272865C142724271 @default.
• W2899272865 hasConceptScore W2899272865C204787440 @default.
• W2899272865 hasConceptScore W2899272865C27081682 @default.
• W2899272865 hasConceptScore W2899272865C2776291583 @default.
• W2899272865 hasConceptScore W2899272865C2778994108 @default.
• W2899272865 hasConceptScore W2899272865C2780149897 @default.
• W2899272865 hasConceptScore W2899272865C2780560023 @default.
• W2899272865 hasConceptScore W2899272865C42219234 @default.
• W2899272865 hasConceptScore W2899272865C71924100 @default.
• W2899272865 hasIssue "6" @default.
• W2899272865 hasLocation W28992728651 @default.
• W2899272865 hasOpenAccess W2899272865 @default.
• W2899272865 hasPrimaryLocation W28992728651 @default.
• W2899272865 hasRelatedWork W1483244905 @default.
• W2899272865 hasRelatedWork W1815673331 @default.
• W2899272865 hasRelatedWork W2007290231 @default.
• W2899272865 hasRelatedWork W2057857872 @default.
• W2899272865 hasRelatedWork W2401336855 @default.
• W2899272865 hasRelatedWork W2405636764 @default.
• W2899272865 hasVolume "45" @default.
• W2899272865 isParatext "false" @default.
• W2899272865 isRetracted "false" @default.
• W2899272865 magId "2899272865" @default.
• W2899272865 workType "article" @default.